Printer Friendly

Periodontal Disease, Inflammatory Cytokines, and PG[E.sub.2] in Pregnant Patients at Risk of Preterm Delivery: A Pilot Study.

1. Introduction

Pregnancy is a physiological process associated with adverse outcomes such as preterm birth (<37 weeks), low birth weight (<2500 grams), or very low birth weight (<1500 grams). The global incidence of preterm delivery is 9.6%, which is equivalent to 12.9 million premature infants. Currently, preterm delivery is the second most common cause of death in children younger than 5 years after pneumonia. Each year, 1 million premature infants die. In addition, preterm birth is associated with deterioration in growth, cognitive and visual alterations, and learning disabilities [1, 2].

The adverse outcomes of pregnancy are associated with elevated systemic inflammatory mediators and intrauterine infections. Current evidence suggests that preterm delivery is primarily due to ascending infections from the vagina or cervix or via hematogenous spread from nongenital sources.

Significant evidence supports an association between the spread of pathogenic bacteria associated with moderate/severe periodontitis and infections and extraoral inflammation. The virulence properties assigned to specific oral pathogenic bacteria (e.g., F. nucleatum, P. gingivalis, C. rectus, among others) might be related to the adverse results of pregnancy, which might partially explain the biological plausibility of the associations among periodontal disease, periodontopathogenic bacteria, systemic inflammatory mediators, and adverse pregnancy outcomes [3].

Maternal periodontitis might represent a nongenital source of microorganisms that, because of their routine entry into the circulation system, have the potential to influence the health of the fetal-maternal pair. Periodontal infection and its pathogens generate virulence factors via the production of lipopolysaccharides (LPSs) and increased cytokines such as tumor necrosis factor- (TNF-) [alpha], interleukin- (IL-) 1, IL2, and IL-6 as well as inflammatory mediators such as prostaglandin E2 (PG[E.sub.2]) [1, 4].

During pregnancy, changes in maternal physiology and metabolism occur; for example, peripheral vascular resistance decreases to compensate for the increases in renin and angiotensin. This effect is attributed to specific prostaglandins (PG[E.sub.2] and PG[I.sub.2]).

In a normal pregnancy, these prostaglandins are synthesized in the fetal membranes: the decidua, the myometrium, and the placenta. The amnion and chorion primarily produce PG[E.sub.2]; the decidua synthesizes PG[E.sub.2] and PGF2; and the myometrium secretes PGI2. The placenta produces a large amount of PGI2 that protects against thrombosis during low pressure in the intervillous space. The production of these substances is proportional to gestational age such that more PGs are present at the end of pregnancy than during the first trimester. Inhibition decreases over time. Prostaglandins also increase the number of myometrium receptors for oxytocin [5, 6].

At the end of a normal term pregnancy (more than 37 weeks) the levels of PG[E.sub.2], TNF-[alpha], and IL-1[beta] are increased until reaching critical levels, which initiates uterine contractions and produces birth [7, 8]. However, during pregnancy and before the end of term, the proinflammatory immune response must be strictly regulated within the uterus to avoid the immune rejection of the fetus. A local increase in proinflammatory mediators can interrupt this delicate balance; therefore, an inflammatory response stimulated by a local infection (e.g., periodontal disease) under this mechanism would contribute to the premature rupture of membranes and uterine contraction, thereby triggering preterm delivery or spontaneous abortion [7, 9,10].

Therefore, the objective of this work was to analyze the cytokines IL-2, IL-6, IL-10, and TNF-[alpha] and inflammatory mediators such as PG[E.sub.2] in pregnant patients at risk of preterm delivery and their relationships with periodontal disease.

2. Materials and Methods

To achieve the proposed objective, a pilot case-control study was conducted.

Pregnant women with a gestational age greater than 20 weeks were considered for inclusion. Patients who received periodontal treatment, antibiotics, or antimicrobials over the last 3 months or who showed active infections or underlying diseases such as diabetes or hypercholesterolemia were excluded from this study.

We analyzed 46 pregnant patients (23 cases and 23 controls). The cases were pregnant patients considered at risk of preterm delivery; the controls were pregnant women not at risk. The evaluated exposure was periodontal disease as a local infection; inflammation and the systemic inflammatory response were analyzed based on the presence of cytokines such as IL-2, IL-6, IL-10, and TNF-[alpha] as well as inflammation mediators such as PG[E.sub.2].

The risk diagnosis of preterm delivery was classified as follows: (1) threat of preterm birth (patients with uterine activity without cervical changes); (2) preterm labor during the initial phase (patients with regular uterine activity with a cervical change less than 4 cm); and (3) advanced phase preterm labor (patients with uterine activity with a cervical change greater than 4 cm). This classification was determined based on the Clinical Practice Guidelines of the Obstetrician-Gynecology Service of San Ignacio University Hospital and was performed by a trained gynecologist [8].

The patients in the case group were hospitalized at San Ignacio University Hospital and presented with the risk of preterm delivery in stages 1 and 2 (i.e., the threat of preterm labor or in the initial phase of preterm labor). Pregnant patients were included in the control group if they had received routine gynecological care on an outpatient basis and did not present with the risk of preterm delivery.

This research was classified as minimal risk in accordance with the regulations established by Resolution 8430, Ministry of Health of Colombia and CIOMS [11, 12]. The Research and Ethics Committees of the Faculties of Dentistry and Medicine at Pontificia Universidad Javeriana provided approval, and each patient was informed about the goals of the research, its scope, and possible benefits before entering the study. After their questions were answered and they showed full understanding of the process in which they would participate, they were asked to sign an informed consent document.

The patients who entered the study provided a blood sample, and two tubes were obtained: one tube to analyze the cholesterol, triglycerides, HDL, LDL, basal glycemia, and hematocrit levels and a second tube to quantify the levels of cytokines and PG[E.sub.2]. The second tube was centrifuged immediately at 10,000 rpm for 10 minutes at room temperature to obtain blood serum and frozen at -20[degrees]C until use. IL-2, IL-6, IL-10, and TNF-[alpha] were quantified using the BD CYTOMETRIC BEAD ARRAY (CBA) Human Th1/Th2 Cytokine Kit II (reference: 55181) following the manufacturer's instructions. Samples were acquired in the Hospital Universitario San Ignacio, using the FACSCanto II flow cytometer from Beckton Dickinson, and the data were analyzed using FCAP Array software.

PG[E.sub.2] was quantified using the ELISA technique via the Human PG[E.sub.2] kit reference KHL1701 (Invitrogen) following the manufacturer's instructions. The absorbance levels were recorded using a spectrophotometer at a wavelength of 412 nm, and the values obtained were transposed to the values given by the standard curve that comes with the kit and replaced in the formula suggested by the kit. Thus, the calculated results were given in picogram units per milliliter (pg/ml).

All of the patients underwent a periodontal evaluation after completing the periodontogram, during which a North Carolina periodontal probe was used. Only two people calibrated to perform periodontal examinations conducted this assessment. Periodontal disease was diagnosed based on the 1999 Armitage classification [13].

For data analysis, the demographic characteristics, the results of the periodontal evaluation, the cytokines, and the PG[E.sub.2] were described using means, medians, ranges, standard deviations, and 95% confidence intervals. A bivariate analysis was performed in which the levels of the cytokines and PG[E.sub.2] were compared between groups, and the periodontal diagnosis was examined using ANOVA after ensuring the normal distribution of the variable data ([alpha] < 0.05).

3. Results

The sample consisted of 46 patients who were divided into two groups based on the risk of preterm delivery. The case group consisted of 23 patients at risk of preterm delivery or high risk (HR) and the control group consisted of 23 patients not at risk or normal (N). The average age was 25.9 years (SD = 6.4 years), and the average gestational age was 29.4 weeks (SD = 4.3). The following periodontal diagnoses were determined: two patients were healthy (4.3%), 21 had gingivitis (45.7%), and 23 had chronic periodontitis (50%).

The mean gestational ages were 31 weeks for women at risk of preterm delivery and 28 weeks for women without risk of preterm delivery (p = 0.466). Both groups had an average age of 26 years.

4. Oral Clinical Characteristics

When analyzing the oral clinical variables with regard to the percentage of biofilm, number of teeth, number of teeth with chronic periodontitis, number of teeth with gingivitis, percentage of teeth with chronic periodontitis, and percentage of teeth with gingivitis, no significant group differences were found. The percentage of biofilm (62%) and the number of teeth with gingivitis (21.8) clinically was higher in the group at risk for preterm delivery, but this difference was not significant (Table 1).

5. Periodontal Diagnosis

The between-group analysis with regard to periodontal diagnosis chronic periodontitis (14 High Risk, 9 Normals), gingivitis (9 High Risk, 12 Normals), and healthy periodontal (0 High Risk, 2 Normals) revealed that more pregnant women in the group at risk of preterm delivery had more chronic periodontitis, and this group had no healthy periodontal patients.

6. Quantification of PG[E.sub.2]

With regard to the level of PG[E.sub.2], an average of 84.4 pg/ml (SD = 23.2) was found, with a minimum of 36.2 pg/ml and a maximum of 157.8 pg/ml. According to the KolmogorovSmirnov test, this variable was normally distributed (p = 0.695), which enabled the later evaluations by group differences (with risk versus without risk) and periodontal diagnosis (healthy versus chronic gingivitis versus chronic periodontitis) (Figure 1).

The comparison of the averages of the two study groups revealed that women at risk for preterm delivery had PG[E.sub.2] levels of 79.9 pg/ml (22.3), whereas those without risk showed PG[E.sub.2] levels of 88.9 pg/ml (SD 23.8); however, this difference was not significant (p = 0.196).

When PG[E.sub.2] was evaluated with regard to periodontal diagnosis, the results revealed that the severity of the periodontal disease increased with the levels of PG[E.sub.2]. No significant differences were found with regard to periodontal diagnosis (p = 0.168), which might be due to the sample sizes of the different groups (Table 2; Figure 2).

The stratified analysis by group and periodontal diagnosis revealed the severity of periodontal disease increased with the level of PG[E.sub.2], regardless of the group to which the woman belonged. The data also showed that these levels were the highest in the group of patients without risk of preterm birth but with chronic periodontitis. No significant differences were found based on group or periodontal diagnosis (p = 0.196; Table 3).

Subsequently, the cut-off point for the level of PG[E.sub.2] was established based on normally distributed reference values (3-12 pg/l). All 46 women in this study, regardless of group or periodontal disease, had high (i.e., abnormal) values of this marker.

7. Quantification of Cytokines

The patients at high risk of preterm birth had higher levels of cytokines (IL-2, IL-6, IL-10, and TNF-[alpha]) than those at low risk; significant differences were observed with regard to IL-2 (p-value 0.013), IL-10 (p-value 0.012), and TNF-[alpha] (p-value 0.010) (Figure 3).

The relationship between cytokines and the severity of periodontal disease revealed that, as the latter appears and increases in severity (from healthy to gingivitis to chronic periodontitis), the levels of the former increase. The highest values were found among patients with chronic periodontitis (Figure 4).

8. Discussion

Childbirth is a complex mechanism which has not been fully elucidated. Most, if not all, events that induce labor can be attributed to the action of the PG[E.sub.2]. In human and nonhuman primates, maternal plasma concentrations of PG[E.sub.2] increase gradually during pregnancy and reach maximum levels at the end of pregnancy. Likewise, COX2 is expressed at low-to-undetectable ranges in the uterus during most of pregnancy, and it is highly regulated by proinflammatory cytokines and PG[E.sub.2]; COX2 catalyzes the production of prostaglandins in the amnion and plays a crucial physiological role in the initiation of labor by functioning as a potent activator of uterine contractions. PG[E.sub.2] is positively regulated during preterm delivery; in turn, it is induced by an inflammatory response that promotes the contraction of the uterine smooth muscle [6,14]. Periodontal disease, with its local and systemic bacterial load, can also trigger a systemic inflammatory response with increased inflammatory cytokines (TNF-[alpha], IL-1, and IL-6) and inflammatory mediators (PG[E.sub.2]) to become a risk factor of preterm delivery.

The present investigation found that, as periodontal disease appeared and increased in its severity (from healthy to gingivitis to chronic periodontitis), the levels of cytokines (IL-2, IL-6, IL-10, and TNF-[alpha]) also increased, such that the highest values were found in pregnant patients with chronic periodontitis. These findings are consistent with the results of Zadeh 1999 [15] and Van Dyke et al. 2013 [16] who indicated that periodontal infection triggers an increase in IL-5, IL-6, IL-4, IL-10, IL-3, and TNF-[alpha] as a systemic inflammatory response.

In addition, investigations such as those by Greig et al. 1997 and Von Minckwitz et al. 2000 [17, 18] have indicated that the increased production of proinflammatory cytokines and inflammatory mediators in patients with periodontal disease, once released, can diffuse into the gingival crevicular fluid (GCF) or enter the bloodstream and reach the placenta-fetus interface. The cytokines IL-1, IL-6, and TNF-[alpha] stimulate the production of prostaglandins in the chorion and exacerbate cervical ripening and uterine contraction, which increase the risk of preterm labor. However, although the elevated serum and amniotic levels of these mediators are associated with several adverse outcomes of pregnancy, Carta et al. (2004), Deortbudak et al. (2005), and Goepfert et al. (2004) reported contradictory evidence by failing to find evidence that the increase of these mediators in gingival crevicular fluid, serum, or amniotic fluid in patients with periodontitis is associated with pregnancy complications [10, 19-21].

When analyzing PG[E.sub.2], the present study showed that, as the severity of periodontal disease increases, the levels of PG[E.sub.2] increased in pregnant women. These findings are similar to those reported by Konopka et al. (2003), who evaluated the relationships among periodontal disease, preterm birth, and low birth weight as well as the levels of PG[E.sub.2] and IL-1[beta] in the gingival crevicular fluid (FCG) and those in the blood serum of women with preterm labor and women who gave birth at term. They found that, in the presence of severe and generalized periodontitis, preterm delivery is 3.9 times more likely compared with women with a healthy periodontium. Among women with preterm delivery, significantly higher concentrations of PG[E.sub.2] and IL-1[beta] were found in the crevicular fluid [22].

Perunovik et al. (2016) evaluated the levels of four factors that trigger labor (PG[E.sub.2], IL-1[beta], IL-6, and TNF-[alpha]) in the gingival crevicular fluid and serum samples among women with preterm birth and term delivery and correlate these levels with periodontal parameters. They found that women with preterm delivery exhibited significantly more periodontitis and showed an increase in the levels of IL-6 and PG[E.sub.2] in the crevicular fluid compared with the term delivery group. Serum levels of PG[E.sub.2] and TNF-[alpha] were positively correlated with probing depth and clinical insertion level (CAL) in women with preterm delivery [23].

The present investigation found that the levels of cytokines (IL-2, IL-6, IL-10, and TNF-[alpha]) were higher in patients at high risk for preterm delivery, supporting what is stated in the literature regarding the role that inflammatory cytokines play in the mechanisms that initiate labor. Similarly, Arntzen et al. (1998) [24] quantified the levels of TNF-[alpha], IL-1, IL-6, and IL-8 in the amniotic fluid of women with preterm and full-term labor and found an association between increases in TNF-[alpha], IL-1, and IL-6 levels and preterm delivery, suggesting that IL-1 plays a dominant role in the presence of chorioamnionitis, whereas IL-6 seems to be more important during preterm idiopathic delivery.

Our results might contribute to the biological plausibility of the relationship between periodontal infection and the risk of preterm delivery and justify what Amare Teshome et al. (2016) reported in a systematic literature review regarding the effect of periodontal disease on preterm delivery and low birth weight, which noted that periodontal disease increased the risk of preterm birth and low birth weight in 9 of the 10 articles analyzed, with an odds ratio (OR) that ranged from 2.04 to 4.19. Only one article did not report this association [25].

Likewise, Corbella et al. (2016) evaluated periodontal disease as an independent risk factor for the adverse outcomes of pregnancy. To accomplish this goal, they performed a meta-analysis to calculate the relative risk (RR) for each pregnancy outcome. The calculated RR of periodontitis was 1.61 for preterm birth assessed across 16 studies (p<0.001); 1.65 for low birth weight assessed across 10 studies (p<0.001); and 3.44 for low preterm birth weight assessed across four studies. They concluded that an association exists, albeit low, between periodontitis and adverse pregnancy outcomes [26].

Scientific evidence has shown some probable mechanisms of the relationship between periodontal disease and adverse outcomes of pregnancy. Unfortunately, the largest multisite randomized trials have failed to show a reduction in preterm birth even when the gold standard of treatment, deep scaling, and root planning was employed. Different meta-analyses show that the randomized clinical trials investigating the effect of periodontal treatment on adverse outcomes are of low quality because of high risk of bias, mainly due to the lack of blinding and to the heterogeneity of the trials [27, 28].

The results of this investigation could not determine whether the differential change of the patient's baseline in inflammatory cytokines and PG[E.sub.2] is an absolute risk factor for preterm birth or if there is a real value beyond the risk of preterm delivery. Many women at risk of preterm labor, in fact, carry it to term. It would be interesting to include in future research only women with actual premature births and to compare them with term delivery controls.

Given the scientific evidence that increasingly supports the role of the systemic inflammatory response generated by remote infections (e.g., periodontal disease) regarding preterm delivery, it is worthwhile and justified to continue researching interdisciplinary groups involving both doctors and dentists to expand the sample and control the possible confounds in such a way that it is possible to visualize the true risk that a pregnant woman with a chronic infection such as periodontal disease might carry with regard to her pregnancy. In addition to this, periodontal disease and preterm delivery are two health problems of interest for public health; for this reason, if periodontal disease can be treated, dentists would be contributing to decrease the risk for preterm delivery.

9. Conclusions

In pregnant women as the severity of the periodontal disease increases, PG[E.sub.2] values increase. We observe that, in patients with chronic periodontitis, both those at high and low risk of preterm delivery had higher levels of PG[E.sub.2]; and patients at high risk for preterm labor and those with periodontitis had higher levels of systemic relevant cytokines that participate in both diseases. For this reason to have periodontal disease can favor the outcome of preterm delivery.

Data Availability

The data used to support the findings of this study are available from the corresponding author upon request.

Conflicts of Interest

No conflicts of commercial interest are present.


The authors thank the Javesalud Institution that collaborated in this research by contributing to the sample of pregnant patients. Additionally, they thank the Flow Cytometry Section of the Clinical Laboratory in Hospital Universitario San Ignacio. The authors report that the research and publication of the article were funded by the Pontificia Universidad Javeriana (Project no. PPTA 5855).


[1] M. Sanz and K. Kornman, "Periodontitis and adverse pregnancy outcomes: Consensus report of the Joint EFP/AAP workshop on periodontitis and systemic diseases," Journal of Clinical Periodontology, vol. 40, no. 14, pp. S164-S169, 2013.

[2] N. Saini and M. Walia, "Relationship between periodontal diseases and preterm birth: Recent epidemiological and biological data," International Journal of Applied and Basic Medical Research, vol. 5, no. 1, p. 2, 2015.

[3] C. M. Cobb, P. J. Kelly, K. B. Wiiliams, S. Babbar, M. Angolkar, and R. J. Derman, "The oral microbiome and adverse pregnancy outcomes," International Journal of Women's Health, vol. 9, pp. 551-559, 2017.

[4] A. Puertas, A. Magan-Fernandez, V. Blanc et al., "Association of periodontitis with preterm birth and low birth weight: a comprehensive review," The Journal of Maternal-Fetal & Neonatal Medicine, vol. 31, no. 5, pp. 597-602,2018.

[5] M. M. Sanchez, Prostaglandinasy Funcion reporductiva.Servicio de Obstetricia y Ginecologaa Hospital Universitario Virgen de las Nieves Granada, 2008, ductiva.pdf.

[6] M. D. Leon Ruiz, Fisiologia Del Inicio Del Parto. Clase de residentes. Hospital Virgen de las Nieves, Granada, Spain, 2007,

[7] G. C. Armitage, "Bi-directional relationship between pregnancy and periodontal disease," Periodontology 2000, vol. 61, no. 1, pp. 160-176, 2013.

[8] Guia Institucional Hospital Universitario San Ignacio, "Intranet Almera. Guia Practica Clinica Parto Pretermino. 2014".

[9] C. W. Africa, "Oral colonization of Gram-negative anaerobes as a risk factor for preterm delivery," Virulence, vol. 2, no. 6, pp. 498-508, 2011.

[10] P. N. Madianos, Y. A. Bobetsis, and S. Offenbacher, "Adverse pregnancy outcomes (APOs) and periodontal disease: Pathogenic mechanisms," Journal of Clinical Periodontology, vol. 40, no. 14, pp. S170-S180, 2013.

[11] "Normas cientificas, tecnicas y administrativas para la investigacion en salud, Resolucion 8430 de 1993, Republica de Colombia," Ministerio de Salud, (1993) Visitado y citado 5de agosto 2017,

[12] Consejo de las Organizaciones Internacionales de Ciencias Medicas (CIOMS), 2010, Guias Eticas Internacionales para la Investigacion Biomedica que involucra 2010, Seres Humanos. [Programa Regional de Bioetica OPS/OMS]. 2-8; Visitado y citado 5de agosto 2017. CIOMS.

[13] G. Armitage, "Diagnostico y clasificacion de las enfermedades periodontales," Periodontoly 2000, vol. 9, no. 7, pp. 9-21, 2005.

[14] H. Li, J. Zhou, X. Wei et al., "MiR-144 and targets, c-fos and cyclooxygenase-2 (COX2), modulate synthesis of PG[E.sub.2] in the amnion during pregnancy and labor," Scientific Reports, vol. 6, no. 1, 2016.

[15] H. H. Zadeh, F. C. Nichols, and K. T. Miyasaki, "The role of the cell-mediated immune response to Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in periodontitis," Periodontology 2000, vol. 20, no. 1, pp. 239-288,1999.

[16] T. E. Van Dyke and A. J. van Winkelhoff, "Infection and inflammatory mechanisms," Journal of Clinical Periodontology, vol. 40, no. 14, pp. S1-S7, 2013.

[17] P. Greig, A. Murtha, C. Jimmerson, W. Herbert, B. Roitmanjohnson, and J. Allen, "Maternal serum interleukin-6 during pregnancy and during term and preterm labor," Obstetrics & Gynecology, vol. 90, no. 3, pp. 465-469,1997.

[18] G. Von Minckwitz, E.-M. Grischke, S. Schwab et al., "Predictive value of serum interleukin-6 and -8 levels in preterm labor or rupture of the membranes," Acta Obstetricia et Gynecologica Scandinavica, vol. 79, no. 8, pp. 667-672, 2000.

[19] G. Carta, G. Persia, K. Falciglia, and P. Iovenitti, "Periodontal disease and poor obstetrical outcome," Clinical and Experimental Obstetrics & Gynecology, vol. 31, no. 1, pp. 47-49, 2004.

[20] O. Dortbudak, R. Eberhardt, M. Ulm, and G. R. Persson, "Periodontitis, a marker of risk in pregnancy for preterm birth," Journal of Clinical Periodontology, vol. 32, no. 1, pp. 45-52, 2005.

[21] A. R. Goepfert, M. K. Jeffcoat, W. W. Andrews et al., "Periodontal disease and upper genital tract inflammation in early spontaneous preterm birth," Obstetrics & Gynecology, vol. 104, no. 4, pp. 777-783, 2004.

[22] T. Konopka, M. Rutkowska, L. Hirnle, W. Kopec, and E. Karolewska, "The secretion of prostaglandin E2 and interleukin 1-beta in women with periodontal diseases and preterm low-birth-weight," Bulletin du Groupement International Pour La Recherche Scientifique en Stomatologie & Odontologie, vol. 45, no. 1, pp. 18-28, 2003.

[23] N. D. Perunovic, M. M. Rakic, L. I. Nikolic et al., "The association between periodontal inflammation and labor triggers (elevated cytokine levels) in preterm birth: A cross-sectional study," Journal of Periodontology, vol. 87, no. 3, pp. 248-256, 2016.

[24] K. J. Arntzen, A. M. Kjollesdal, J. Halgunset, L. Vatten, and R. Austgulen, "TNF, IL-1, IL-6, IL-8 and soluble TNF receptors in relation to chorioamnionitis and premature labor," Journal of Perinatal Medicine, vol. 26, no. 1, pp. 17-26,1998.

[25] A. Teshome and A. Yitayeh, "Relationship between periodontal disease and preterm low birth weight: Systematic review," Pan African Medical Journal, vol. 24, article no. 215, 2016.

[26] S. Corbella, S. Taschieri, M. Del Fabbro, L. Francetti, R. Weinstein, and E. Ferrazzi, "Adverse pregnancy outcomes and periodontitis: A systematic review and meta-analysis exploring potential association," Quintessence International, vol. 47, no. 3, pp. 193-204, 2016.

[27] Z. Iheozor-Ejiofor, P. Middleton, M. Esposito, and A. M. Glenny, "Treating periodontal disease for preventing adverse birth outcomes in pregnant women," The Cochrane Database of Systematic Reviews, vol. 6, 2017.

[28] S. Spivakovsky, "Periodontal treatment for the prevention of adverse birth outcomes," Evidence-Based Dentistry, vol. 19, no. 1, pp. 12-13, 2018.

Catalina Latorre Uriza, (1) Juliana Velosa-Porras, (2) Nelly S. Roa, (2) Stephani Margarita Quinones Lara, (2) Jaime Silva, (3) Alvaro J. Ruiz, (4) and Francina Maria Escobar Arregoces (iD)(1)

(1) Centro de Investigaciones Odontologicas (CIO), Professor Graduate Program in Periodontics, Faculty of Dentistry, Pontificia Universidad Javeriana, Colombia

(2) Centro de Investigaciones Odontologicas (CIO), Faculty of Dentistry, Pontificia Universidad Javeriana, Bogota, Colombia

(3) Hospital Universitario San Ignacio, Colombia

(4) Department of Clinical Epidemiology and Biostatistics, Faculty of Medicine, Pontificia Universidad Javeriana, Colombia

Correspondence should be addressed to Francina Maria Escobar Arregoces;

Received 2 May 2018; Accepted 27 June 2018; Published 1 August 2018

Academic Editor: Patrick Ramsey

Caption: Figure 1: PG[E.sub.2] levels by risk. Expression of PG[E.sub.2] in case group patients at risk of preterm delivery (High Risk) and the control group not at risk (Normal), n=23 per group. The PG[E.sub.2] levels was quantified by ELISA and compared between groups by a bivariate analysis. The data are represented by the median for each group.

Caption: Figure 2: PG[E.sub.2] levels by periodontal diagnosis. Expression of PG[E.sub.2] in gingivitis (n=21), chronic periodontitis (n=23), and healthy (n=2). The PG[E.sub.2] levels was quantified by ELISA and compared between groups by a bivariate analysis. The data are represented by the median for each group.

Caption: Figure 3: The quantification of systemic cytokines in pregnant patients with (High Risk) and without the risk (Normal) of preterm birth. TNF-[alpha], IL-10, IL-6, and IL-2 were quantified using the CBA and by Flow Cytometer 50,000 events were acquired and analyzed using FCAP Array software. The concentrations obtained were expressed in pg/ml and compared between groups by a bivariate analysis. The data are represented by the median for each group (n=23 per group).

Caption: Figure 4: Quantification of cytokines by periodontal disease. Expression TNF-[alpha], IL-10, IL-6, and IL-2 in gingivitis (n=21), chronic periodontitis (n=23), and healthy (n=2). Systemic cytokines were quantified using the CBA and by Flow Cytometer 50,000 events were acquired and analyzed using FCAP Array software. The concentrations obtained were expressed in pg/ml and compared between groups by a bivariate analysis. The data are represented by the median for each group.
Table 1: Oral clinical characteristics by group.


                               Risk    No risk    p-value

% Biofilm                       62      45.8       0.519
# Teeth                         28      27.9       0.249
# Teeth with periodontitis     2.5       2.0       0.642
# Teeth with gingivitis        21.8     17.4       0.050

Table 2: PGE2 levels by periodontal diagnosis.

Periodontal diagnosis            Average PG[E.sub.2]    SD

Healthy (n = 2)                         76.31          16.37
Gingivitis (n = 21)                     78.11          23.76
Chronic Periodontitis (n = 23)          90.92          22.21

Table 3: PG[E.sub.2] levels by risk of preterm delivery and
periodontal diagnosis.

Group              Periodontal diagnosis         Average        SD

High risk        Chronic gingivitis (n = 9)        70.86      24.83
               Chronic periodontitis (n = 14)      85.83      19.24
                      Healthy (n = 2)              76.31      16.37
Low risk        Chronic gingivitis (n = 12)        83.55      22.42
               Chronic periodontitis (n = 9)       98.83      25.29
COPYRIGHT 2018 Hindawi Limited
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2018 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Research Article
Author:Uriza, Catalina Latorre; Velosa-Porras, Juliana; Roa, Nelly S.; Lara, Stephani Margarita Quinones; S
Publication:Infectious Diseases in Obstetrics and Gynecology
Date:Jan 1, 2018
Previous Article:Universal Rapid Human Immunodeficiency Virus Screening at Delivery: A Cost-Effectiveness Analysis.
Next Article:Time-Kill Kinetics of Rezafungin (CD101) in Vagina-Simulative Medium for Fluconazole-Susceptible and Fluconazole-Resistant Candida albicans and...

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |